Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark. CLPBY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

If Amazon were to enter the home health supply distribution, this could put price pressure on Coloplast and other chronic care product manufacturers.

Coloplast's wound-care portfolio is relatively limited, especially when compared with the breadth of products from Smith & Nephew, and ConvaTec, which includes high-tech solutions such as negative-pressure wound therapy, gels, and hydrofiber dressings.

Now that Coloplast has already shifted most of its manufacturing to low-cost geographies, gains in gross margin may not be so easy to achieve.

The U.S. remains one of the largest ostomy-care and continence markets, and Coloplast has beefed up its footprint and made inroads in that geography by landing key GPO contracts.

Growing household income coupled with healthcare reform is making emerging markets an attractive target for Coloplast.

Because of aging populations in developed countries, the incidence of colorectal disease is growing. Independent of age, the incidence of inflammatory bowel disease is also on the rise.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Full disclosure

Coloplast

Why Robinhood?

About CLPBY

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care.

CLPBY Key Statistics

Analyst ratings

55%

Coloplast

Why Robinhood?

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. Show more

CLPBY Key Statistics

Analyst ratings

55%

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care.